Eligibility Prostate Cancer NCT00193193

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the prostate not curable with local treatment
Description

Prostate cancer

Data type

boolean

Alias
UMLS CUI [1]
C0600139
disease progression while receiving hormonal therapy
Description

Disease progression while hormonal therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0279025
measurable or evaluable disease
Description

Measurable or evaluable disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
previous treatment with a maximum of one prior chemotherapy regimen
Description

Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
ecog performance status 0, 1, or 2.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, liver and kidney function
Description

Bone marrow, liver and kidney function

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0005953
UMLS CUI [3]
C0232804
able to comprehend the nature of this study and give written informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Description

Exclusion criteria

Data type

boolean

Alias
UMLS CUI [1]
C0680251
age < 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
history of treatment for an invasive malignancy within five years
Description

Cancer treatment

Data type

boolean

Alias
UMLS CUI [1]
C0920425
significant heart disease
Description

Heart disease

Data type

boolean

Alias
UMLS CUI [1]
C0018799
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Description

Inclusion and exclusion criteria

Data type

boolean

Alias
UMLS CUI [1]
C1512693
UMLS CUI [2]
C0680251

Similar models

Eligibility Prostate Cancer NCT00193193

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Prostate cancer
Item
adenocarcinoma of the prostate not curable with local treatment
boolean
C0600139 (UMLS CUI [1])
Disease progression while hormonal therapy
Item
disease progression while receiving hormonal therapy
boolean
C0242656 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
Measurable or evaluable disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Chemotherapy
Item
previous treatment with a maximum of one prior chemotherapy regimen
boolean
C0392920 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, or 2.
boolean
C1520224 (UMLS CUI [1])
Bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed consent
Item
able to comprehend the nature of this study and give written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion criteria
Item
you cannot participate in this study if any of the following apply to you:
boolean
C0680251 (UMLS CUI [1])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Cancer treatment
Item
history of treatment for an invasive malignancy within five years
boolean
C0920425 (UMLS CUI [1])
Heart disease
Item
significant heart disease
boolean
C0018799 (UMLS CUI [1])
Inclusion and exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1512693 (UMLS CUI [1])
C0680251 (UMLS CUI [2])